We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

Back to rankings

80 hedge funds and large institutions have $199M invested in Syneron Medical Ltd in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 4

256% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 9

23% more funds holding

Funds holding: 65 → 80 (+15)

22% more capital invested

Capital invested by funds: $163M → $199M (+$35.9M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

94% less call options, than puts

Call options by funds: $84K | Put options by funds: $1.39M

Holders
80
Holders Change
+15
Holders Change %
+23.08%
% of All Funds
2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
20
Increased
32
Reduced
9
Closed
4
Calls
$84K
Puts
$1.39M
Net Calls
-$1.3M
Net Calls Change
-$1.21M

Top Buyers

Rank Fund Capital Flow
1
HP
HealthInvest Partners
Sweden
+$5.53M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.29M
3
KCP
Kenmare Capital Partners
New York
+$2.11M
4
BIP
Brandes Investment Partners
California
+$1.93M
5
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
+$1.85M

Top Sellers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
-$2.75M
2
GIM
Granahan Investment Management
Massachusetts
-$1.31M
3
SM
Senvest Management
New York
-$513K
4
California Public Employees Retirement System
California Public Employees Retirement System
California
-$159K
5
Wolverine Trading
Wolverine Trading
Illinois
-$130K
Name Holding Trade Value Shares
Change 		Change in
Stake
PIM
26
Profit Investment Management
Maryland
$746K – – –
DCM
27
DAFNA Capital Management
California
$722K – – –
CM
28
Crestline Management
Texas
$687K +$221K +28,181 +53%
BIT
29
BlackRock Institutional Trust
California
$606K +$115K +14,613 +25%
State Street
30
State Street
Massachusetts
$602K +$200K +25,553 +56%
RA
31
Royce & Associates
New York
$581K -$2.75M -351,459 -84%
CCP
32
Clough Capital Partners
Massachusetts
$543K +$507K +64,700 New
OAM
33
Oxford Asset Management
United Kingdom
$536K +$380K +48,426 +315%
MC
34
Moors & Cabot
Massachusetts
$477K +$9.8K +1,250 +2%
QI
35
QS Investors
New York
$448K – – –
Creative Planning
36
Creative Planning
Kansas
$418K +$365K +46,600 +1,456%
Russell Investments Group
37
Russell Investments Group
United Kingdom
$409K +$374K +47,740 New
Geode Capital Management
38
Geode Capital Management
Massachusetts
$367K +$119K +15,159 +53%
Goldman Sachs
39
Goldman Sachs
New York
$297K +$187K +23,803 +207%
PCM
40
Prelude Capital Management
New York
$295K +$233K +29,712 +550%
State of Tennessee, Department of Treasury
41
State of Tennessee, Department of Treasury
Tennessee
$287K +$267K +34,112 New
Invesco
42
Invesco
Georgia
$274K -$3.73K -476 -1%
AIM
43
Acrospire Investment Management
Illinois
$265K +$247K +31,499 New
COPPSERS
44
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$262K +$120K +15,312 +96%
HHC
45
Hutchin Hill Capital
New York
$258K +$241K +30,700 New
Morgan Stanley
46
Morgan Stanley
New York
$257K +$215K +27,493 +859%
Simplex Trading
47
Simplex Trading
Illinois
$238K +$213K +27,133 +2,145%
TI
48
Trexquant Investment
Connecticut
$235K +$219K +27,984 New
Jane Street
49
Jane Street
New York
$230K +$215K +27,368 New
EGA
50
Eagle Global Advisors
Texas
$219K +$205K +26,100 New
1
2
3 4

ELOS Hedge Fund Activity: Q4 2016 in Review

80 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q4 2016, worth a combined $199M — up 22% from $163M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new ELOS positions and 4 closed out — a net gain of 16 holders — while 32 added to existing stakes and 9 trimmed.

The largest buyer was HealthInvest Partners, opening a new position worth an estimated $5.53M. The largest seller was Royce & Associates, cutting an estimated $2.75M.

  • 80 institutional investors held Syneron Medical Ltd (ELOS) as of Q4 2016, up from 65 in Q3 2016.
  • Funds reported $199M of Syneron Medical Ltd stock for Q4 2016, up 22% quarter-over-quarter.
  • 20 funds opened new Syneron Medical Ltd positions in Q4 2016 and 4 closed out, a net change of +16 holders.
  • The largest Syneron Medical Ltd buyer in Q4 2016 was HealthInvest Partners, an estimated $5.53M added.
  • The largest Syneron Medical Ltd seller in Q4 2016 was Royce & Associates, an estimated $2.75M sold.

Based on aggregated 13F filings for Q4 2016.